67 related articles for article (PubMed ID: 20951742)
1. Mutual benefits of B-ALL and HLDA/HCDM HLDA 9th Barcelona 2010.
Faure GC; Amsellem S; Arnoulet C; Bardet V; Campos L; De Carvalho-Bittencourt M; de Labarthe A; Eischen A; Feuillard J; Fossat C; Ottou FG; Guérin E; Guy J; Jouault H; Kuhlein E; Lacombe F; Lainey E; Maynadié M; Noguera ME; Roussel M; Solly F; Ballon OW; Béné MC;
Immunol Lett; 2011 Jan; 134(2):145-9. PubMed ID: 20951742
[TBL] [Abstract][Full Text] [Related]
2. A new approach of acute lymphoblastic leukemia immunophenotypic classification: 1984-1994 the GEIL experience. Groupe d'Etude Immunologique des Leucémies.
Garand R; Béné MC
Leuk Lymphoma; 1994; 13 Suppl 1():1-5. PubMed ID: 7915591
[TBL] [Abstract][Full Text] [Related]
3. Standardized multicentric quantimetry of differentiation antigens expression. The GEIL's approach in acute lymphoblastic leukemia. Groupe d'Etude Immunologique des Leucémies.
Philip P; Sartiaux C
Leuk Lymphoma; 1994; 13 Suppl 1():45-8. PubMed ID: 8075579
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive flow cytometry phenotype in acute leukemia at diagnosis and at relapse.
Li X; Du W; Liu W; Li X; Li H; Huang SA
APMIS; 2010 May; 118(5):353-9. PubMed ID: 20477810
[TBL] [Abstract][Full Text] [Related]
5. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens.
Kalina T; Vaskova M; Mejstrikova E; Madzo J; Trka J; Stary J; Hrusak O
BMC Cancer; 2005 Apr; 5():38. PubMed ID: 15826304
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
7. Immunologic analysis of a thousand cases of acute leukemia. French Groupe d'Etude Immunologique des Leucémies (GEIL).
Béné MC; Boumsell L; Vannier JP; Garand R; Solary E; Faure G; Bernard A
Nouv Rev Fr Hematol (1978); 1989; 31(2):133-6. PubMed ID: 2671926
[TBL] [Abstract][Full Text] [Related]
8. [Immunophenotyping of eighty six children with acute lymphoblastic leukemia by three-color flow cytometry].
Wan S; Gong W; Sun X; Xu J; Tian D
Zhonghua Xue Ye Xue Za Zhi; 2002 Feb; 23(2):83-6. PubMed ID: 12015077
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping.
Bavikatty NR; Ross CW; Finn WG; Schnitzer B; Singleton TP
Hum Pathol; 2000 Sep; 31(9):1051-4. PubMed ID: 11014570
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases.
Chevallier P; Robillard N; Houille G; Ayari S; Guillaume T; Delaunay J; Harousseau JL; Avet-Loiseau H; Mohty M; Garand R
Leukemia; 2009 Apr; 23(4):806-7. PubMed ID: 18971949
[No Abstract] [Full Text] [Related]
12. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression.
Cascavilla N; Musto P; D'Arena G; Ladogana S; Matera R; Carotenuto M
Haematologica; 1997; 82(1):31-7. PubMed ID: 9107079
[TBL] [Abstract][Full Text] [Related]
13. Panel proposal for the immunophenotypic diagnosis of hematological malignancies. A collaborative consensus from the groupe d'Etude Immunologique des Leucémies (GEIL).
Collective Publication
Cytometry B Clin Cytom; 2018 May; 94(3):542-547. PubMed ID: 29160946
[TBL] [Abstract][Full Text] [Related]
14. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
Babusíková O; Glasová M; Koníková E; Kusenda J
Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
[TBL] [Abstract][Full Text] [Related]
15. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
Wiersma SR; Ortega J; Sobel E; Weinberg KI
N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
[TBL] [Abstract][Full Text] [Related]
16. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
17. [Immunophenotyping with flow cytometry in patients with acute leukemia].
Mociková H; Mociková K; Wildová B; Kohútová M; Bubanská E
Vnitr Lek; 1996 Jul; 42(7):454-7. PubMed ID: 8928420
[TBL] [Abstract][Full Text] [Related]
18. CD10 in acute leukemias. GEIL (Groupe d'Etude Immunologique des Leucémies).
Béné MC; Faure GC
Haematologica; 1997; 82(2):205-10. PubMed ID: 9175328
[TBL] [Abstract][Full Text] [Related]
19. Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome.
Griesinger F; Pirò-Noack M; Kaib N; Falk M; Renziehausen A; Troff C; Grove D; Schnittger S; Büchner T; Ritter J; Hiddemann W; Wörmann B
Br J Haematol; 1999 Apr; 105(1):241-55. PubMed ID: 10233388
[TBL] [Abstract][Full Text] [Related]
20. CD2 + CD19 + acute lymphoblastic leukaemia in 16 children and adults: clinical and biological features. Groupe d'Etude Immunologique des Leucémies (G.E.I.L.).
Lenormand B; Vannier JP; Bene MC; Falkenrodt A; Bayle C; Favre M; Garand R; Griveau AM; Briquet MT; Reman O
Br J Haematol; 1993 Apr; 83(4):580-8. PubMed ID: 7686033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
